Evidence map›Paper›PMID 18622403›Full record

ArticleNature medicine2008

Adenovirus-mediated gene expression imaging to directly detect sentinel lymph node metastasis of prostate cancer.

Jeremy B Burton, Mai Johnson, Makoto Sato, Sok Boon S Koh, David J Mulholland, David Stout, Arion F Chatziioannou, Michael E Phelps, Hong Wu, Lily Wu

Open access · greenAbstract read
In one paragraph

Article in Nature medicine, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Development of dual reporter imaging system forClinical and experimental vaccine research · 2018
    Article
  6. Multiparametric Imaging of Organ System Interfaces.Circulation. Cardiovascular imaging · 2017
    Review
  7. Article
  8. Biological ablation of sentinel lymph node metastasis in submucosally invaded early gastrointestinal cancer.Molecular therapy : the journal of the American Society of Gene Therapy · 2015
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Bioluminescent orthotopic model of pancreatic cancer progression.Journal of visualized experiments : JoVE · 2013
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Molecular imaging of prostate cancer: PET radiotracers.AJR. American journal of roentgenology · 2012
    Review
  19. Cancer imaging: Gene transcription-based imaging and therapeutic systems.The international journal of biochemistry & cell biology · 2012
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Jeremy B BurtonDepartment of Molecular and Medical Pharmacology, Crump Institute for Molecular Imaging and Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California 90095-1735, USA.
Mai Johnson
Makoto Sato
Sok Boon S Koh
David J Mulholland
David Stout
Arion F Chatziioannou
Michael E Phelps
Hong Wu
Lily Wu
University of California, Los Angeles · USUCLA Jonsson Comprehensive Cancer Center

Funding

UCLA SPORE IN PROSTATE CANCERP50CA092131 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI REITER, ROBERT E · 2002 to 2023
$42.6M
Gene-Based Imaging and Therapy To Target Prostate CancerR01CA101904 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WU, LILY · 2003 to 2012
$2.9M
The UCLA Imaging Resource for Mouse Cancer ModelsU24CA092865 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CHATZIIOANNOU, ARION XENOFON, PHELPS, MICHAEL E · 2007 to 2011
$2.2M
RESEARCH TRAINING IN PHARMACOLOGICAL SCIENCEST32GM008652 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HERSCHMAN, HARVEY R. · 1998 to 2005
$1.1M
PET-guided Intervention in Lymphatic Metastasis of Prostate CancerR21CA122693 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WU, LILY · 2007 to 2008
$340k
NCI NIH HHS 2U24 CA092865NCI NIH HHS P50 CA092131NCI NIH HHS R01 CA101904NCI NIH HHS R01 CA101904-01NCI NIH HHS R21 CA122693NCI NIH HHS U24 CA092865NIGMS NIH HHS T32 GM008652NIGMS NIH HHS T32-GM008652
6 · The paper itself

Abstract

The accurate assessment of nodal involvement in prostate cancer is crucial to planning treatment, yet there is a shortage of noninvasive imaging techniques capable of visualizing nodal lesions directly. This study demonstrates the feasibility of using recombinant human adenoviral vectors to detect nodal metastases in a human prostate cancer model. This was achieved by the prostate-restricted expression of optical and positron emission tomography (PET) imaging reporter genes by the viral vector coupled with the innate lymphotropic properties of adenovirus. We show that peritumoral administration of these vectors results in the direct detection of reporter gene expression in metastatic lesions within sentinel lymph nodes. Notably, this approach parallels the current lymphoscintigraphy method but enables the direct PET visualization of sentinel lymph node metastases, eliminating the need for invasive lymphadenectomy. These findings may lead to more effective diagnostic and therapeutic strategies for individuals with advanced-stage prostate cancer.

Indexed as

Gene Expression Regulation, ViralAdenoviridaeAnimalsHumansIndolesLymphatic MetastasisLymph NodesMaleMiceMice, TransgenicNeoplasm MetastasisNeoplasm TransplantationPositron-Emission TomographyProstatic NeoplasmsTomography, X-Ray ComputedIndolesSCIO-469

Identifiers

PMID18622403
PMCPMC2811163
OpenAlexW2054545020

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.